PharmaBiome is a spin-off company of ETH Zurich, and has developed a technology platform for the production of standardized microbiome-based products. The NicheMap is a drug-development platform which includes an in vitro culture based technology enabling the quantitative understanding of the link between microbiome composition and activity.